CD8A and Merkel cell skin cancer: To test the ability of 4-1BBL/IL-12NPs to reprogram MCC cellsand activate antitumor immune responses, we transfected MCC cellswith 4-1BBL/IL-12 NPs and cocultured them with human CD8+ T cellsthe following day.